A drug with the SMILES Cc1nc(N2CCN(c3ccccn3)CC2)c2c(C)c(C(=O)N3CCN(c4cccc(Cl)c4)CC3)sc2n1 has a hERG inhibition at a concentration of 1uM of 15.331\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1nc(N2CCN(c3ccccn3)CC2)c2c(C)c(C(=O)N3CCN(c4cccc(Cl)c4)CC3)sc2n1
Cc1nc(N2CCN(c3ccccn3)CC2)c2c(C)c(C(=O)N3CCN(c4cccc(Cl)c4)CC3)sc2n1
[4-(3-chlorophenyl)piperazin-1-yl]-[2,5-dimethyl-4-(4-pyridin-2-ylpiperazin-1-yl)thieno[2,3-d]pyrimidin-6-yl]methanone